Schoenberger SP - Search Results

1

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.

Singh-Jasuja H, Toes RE, Spee P, Münz C, Hilf N, Schoenberger SP, Ricciardi-Castagnoli P, Neefjes J, Rammensee HG, Arnold-Schild D, Schild H. Singh-Jasuja H, et al. Among authors: schoenberger sp. J Exp Med. 2000 Jun 5;191(11):1965-74. doi: 10.1084/jem.191.11.1965. J Exp Med. 2000. PMID: 10839811 Free PMC article.

2

Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.

Toes RE, Offringa R, Feltkamp MC, Visseren MJ, Schoenberger SP, Melief CJ, Kast WM. Toes RE, et al. Among authors: schoenberger sp. Behring Inst Mitt. 1994 Jul;(94):72-86. Behring Inst Mitt. 1994. PMID: 7998917 Review.

3

Activation or frustration of anti-tumor responses by T-cell-based immune modulation.

Toes RE, Schoenberger SP, van der Voort EI, Kast WM, Hoeben RC, Melief CJ, Offringa R. Toes RE, et al. Among authors: schoenberger sp. Semin Immunol. 1997 Oct;9(5):323-7. doi: 10.1006/smim.1997.0088. Semin Immunol. 1997. PMID: 9327527 Review.

4

Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells.

Toes RE, van der Voort EI, Schoenberger SP, Drijfhout JW, van Bloois L, Storm G, Kast WM, Offringa R, Melief CJ. Toes RE, et al. Among authors: schoenberger sp. J Immunol. 1998 May 1;160(9):4449-56. J Immunol. 1998. PMID: 9574550

5

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. Schoenberger SP, et al. Nature. 1998 Jun 4;393(6684):480-3. doi: 10.1038/31002. Nature. 1998. PMID: 9624005

6

Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC.

Schoenberger SP, Jonges LE, Mooijaart RJ, Hartgers F, Toes RE, Kast WM, Melief CJ, Offringa R. Schoenberger SP, et al. Cancer Res. 1998 Jul 15;58(14):3094-100. Cancer Res. 1998. PMID: 9679976

7

Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells.

Schoenberger SP, van der Voort EI, Krietemeijer GM, Offringa R, Melief CJ, Toes RE. Schoenberger SP, et al. J Immunol. 1998 Oct 15;161(8):3808-12. J Immunol. 1998. PMID: 9780143

8

CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity.

Toes RE, Schoenberger SP, van der Voort EI, Offringa R, Melief CJ. Toes RE, et al. Among authors: schoenberger sp. Semin Immunol. 1998 Dec;10(6):443-8. doi: 10.1006/smim.1998.0147. Semin Immunol. 1998. PMID: 9826577 Review.

9

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.

Diehl L, den Boer AT, Schoenberger SP, van der Voort EI, Schumacher TN, Melief CJ, Offringa R, Toes RE. Diehl L, et al. Among authors: schoenberger sp. Nat Med. 1999 Jul;5(7):774-9. doi: 10.1038/10495. Nat Med. 1999. PMID: 10395322

10

Role of antigen-presenting cells in mediating tolerance and autoimmunity.

Garza KM, Chan SM, Suri R, Nguyen LT, Odermatt B, Schoenberger SP, Ohashi PS. Garza KM, et al. Among authors: schoenberger sp. J Exp Med. 2000 Jun 5;191(11):2021-7. doi: 10.1084/jem.191.11.2021. J Exp Med. 2000. PMID: 10839816 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters